Reversal of West Nile virus-induced blood-brain barrier disruption and tight junction proteins degradation by matrix metalloproteinases inhibitor

Virology

Volumn 397, Issue 1, 2010, Pages 130-138

  Verma, Saguna ^a   Kumar, Mukesh ^a   Gurjav, Ulziijargal ^a,b   Lum, Stephanie ^a   Nerurkar, Vivek R ^a,b  

^a UNIVERSITY OF HAWAII   (United States)

^b UNIVERSITY OF HAWAII   (United States)

Author keywords

Astrocytes; BBB; Claudin 1; GM6001; Human brain microvascular endothelial cells; Meningoencephalitis; MMP; Tight junction proteins; TIMP; ZO 1

Indexed keywords

CELL PROTEIN; GELATINASE B; ILOMASTAT; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; STROMELYSIN; TIGHT JUNCTION PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOCOMPETENT CELL; IMMUNOCYTOCHEMISTRY; IN VITRO STUDY; NEUROPATHOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUPERNATANT; VIRUS INFECTION; WEST NILE FLAVIVIRUS; WESTERN BLOTTING; ZYMOGRAPHY;

ASTROCYTES; BLOOD-BRAIN BARRIER; DIPEPTIDES; ENDOTHELIAL CELLS; GENE EXPRESSION PROFILING; HUMANS; MATRIX METALLOPROTEINASES; MEMBRANE PROTEINS; PHOSPHOPROTEINS; PROTEASE INHIBITORS; TIGHT JUNCTIONS; WEST NILE VIRUS;

WEST NILE VIRUS;

EID: 73949154760     PISSN: 00426822     EISSN: 10960341     Source Type: Journal    
DOI: 10.1016/j.virol.2009.10.036     Document Type: Article

References (52)

1. Afonso P.V., Ozden S., Prevost M.C., Schmitt C., Seilhean D., Weksler B., Couraud P.O., Gessain A., Romero I.A., and Ceccaldi P.E. Human blood-brain barrier disruption by retroviral-infected lymphocytes: role of myosin light chain kinase in endothelial tight-junction disorganization. J. Immunol. 179 4 (2007) 2576-2583
2. Amantea D., Russo R., Gliozzi M., Fratto V., Berliocchi L., Bagetta G., Bernardi G., and Corasaniti M.T. Early upregulation of matrix metalloproteinases following reperfusion triggers neuroinflammatory mediators in brain ischemia in rat. Int. Rev. Neurobiol. 82 (2007) 149-169
3. Anthony D.C., Ferguson B., Matyzak M.K., Miller K.M., Esiri M.M., and Perry V.H. Differential matrix metalloproteinase expression in cases of multiple sclerosis and stroke. Neuropathol. Appl. Neurobiol. 23 5 (1997) 406-415
4. Arjona A., Foellmer H.G., Town T., Leng L., McDonald C., Wang T., Wong S.J., Montgomery R.R., Fikrig E., and Bucala R. Abrogation of macrophage migration inhibitory factor decreases West Nile virus lethality by limiting viral neuroinvasion. J. Clin. Invest. 117 10 (2007) 3059-3066
5. Arjona A., Ledizet M., Anthony K., Bonafe N., Modis Y., Town T., and Fikrig E. West Nile virus envelope protein inhibits dsRNA-induced innate immune responses. J. Immunol. 179 12 (2007) 8403-8409
6. Chapagain M.L., Verma S., Mercier F., Yanagihara R., and Nerurkar V.R. Polyomavirus JC infects human brain microvascular endothelial cells independent of serotonin receptor 2A. Virology 364 1 (2007) 55-63
7. Chaudhuri A., Yang B., Gendelman H.E., Persidsky Y., and Kanmogne G.D. STAT1 signaling modulates HIV-1-induced inflammatory responses and leukocyte transmigration across the blood-brain barrier. Blood 111 4 (2008) 2062-2072
8. Cheeran M.C., Hu S., Sheng W.S., Rashid A., Peterson P.K., and Lokensgard J.R. Differential responses of human brain cells to West Nile virus infection. J. Neurovirol. 11 6 (2005) 512-524
9. Chen K.M., Liu J.Y., Lai S.C., Hsu L.S., and Lee H.H. Association of plasminogen activators and matrix metalloproteinase-9 proteolytic cascade with blood-CNS barrier damage of angiostrongyliasis. Int. J. Exp. Pathol. 87 2 (2006) 113-119
10. Cheng Y., King N.J., and Kesson A.M. The role of tumor necrosis factor in modulating responses of murine embryo fibroblasts by flavivirus, West Nile. Virology 329 2 (2004) 361-370
11. Chua P.K., Melish M.E., Yu Q., Yanagihara R., Yamamoto K.S., and Nerurkar V.R. Elevated levels of matrix metalloproteinase 9 and tissue inhibitor of metalloproteinase 1 during the acute phase of Kawasaki disease. Clin. Diagn. Lab. Immunol. 10 2 (2003) 308-314
12. Conant K., Haughey N., Nath A., St Hillaire C., Gary D.S., Pardo C.A., Wahl L.M., Bilak M., Milward E., and Mattson M.P. Matrix metalloproteinase-1 activates a pertussis toxin-sensitive signaling pathway that stimulates the release of matrix metalloproteinase-9. J. Neurochem. 82 4 (2002) 885-893
13. Conant K., McArthur J.C., Griffin D.E., Sjulson L., Wahl L.M., and Irani D.N. Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann. Neurol. 46 3 (1999) 391-398
14. Cunningham L.A., Wetzel M., and Rosenberg G.A. Multiple roles for MMPs and TIMPs in cerebral ischemia. Glia 50 4 (2005) 329-339
15. Diamond M.S., and Klein R.S. West Nile virus: crossing the blood-brain barrier. Nat. Med. 10 12 (2004) 1294-1295
16. Diamond M.S., Shrestha B., Mehlhop E., Sitati E., and Engle M. Innate and adaptive immune responses determine protection against disseminated infection by West Nile encephalitis virus. Viral. Immunol. 16 3 (2003) 259-278
17. Diniz J.A., Da Rosa A.P., Guzman H., Xu F., Xiao S.Y., Popov V.L., Vasconcelos P.F., and Tesh R.B. West Nile virus infection of primary mouse neuronal and neuroglial cells: the role of astrocytes in chronic infection. Am. J. Trop. Med. Hyg. 75 4 (2006) 691-696
18. Gearing A.J., Beckett P., Christodoulou M., Churchill M., Clements J.M., Crimmin M., Davidson A.H., Drummond A.H., Galloway W.A., Gilbert R., et al. Matrix metalloproteinases and processing of pro-TNF-alpha. J. Leukoc. Biol. 57 5 (1995) 774-777
19. Hayes E.B., and Gubler D.J. West Nile virus: epidemiology and clinical features of an emerging epidemic in the United States. Annu. Rev. Med. 57 (2006) 181-194
20. Hu J., Van den Steen P.E., Sang Q.X., and Opdenakker G. Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases. Nat. Rev. Drug. Discov. 6 6 (2007) 480-498
21. Hummel V., Kallmann B.A., Wagner S., Fuller T., Bayas A., Tonn J.C., Benveniste E.N., Toyka K.V., and Rieckmann P. Production of MMPs in human cerebral endothelial cells and their role in shedding adhesion molecules. J. Neuropathol. Exp. Neurol. 60 4 (2001) 320-327
22. Johnatty R.N., Taub D.D., Reeder S.P., Turcovski-Corrales S.M., Cottam D.W., Stephenson T.J., and Rees R.C. Cytokine and chemokine regulation of proMMP-9 and TIMP-1 production by human peripheral blood lymphocytes. J. Immunol. 158 5 (1997) 2327-2333
23. Johnston J.B., Zhang K., Silva C., Shalinsky D.R., Conant K., Ni W., Corbett D., Yong V.W., and Power C. HIV-1 Tat neurotoxicity is prevented by matrix metalloproteinase inhibitors. Ann. Neurol. 49 2 (2001) 230-241
24. Kanmogne G.D., Schall K., Leibhart J., Knipe B., Gendelman H.E., and Persidsky Y. HIV-1 gp120 compromises blood-brain barrier integrity and enhances monocyte migration across blood-brain barrier: implication for viral neuropathogenesis. J. Cereb. Blood Flow Metab. 27 1 (2007) 123-134
25. Keogh B., Sheahan B.J., Atkins G.J., and Mills K.H. Inhibition of matrix metalloproteinases ameliorates blood-brain barrier disruption and neuropathological lesions caused by avirulent Semliki Forest virus infection. Vet. Immunol. Immunopathol. 94 3-4 (2003) 185-190
26. Kim Y.S., Kim S.S., Cho J.J., Choi D.H., Hwang O., Shin D.H., Chun H.S., Beal M.F., and Joh T.H. Matrix metalloproteinase-3: a novel signaling proteinase from apoptotic neuronal cells that activates microglia. J. Neurosci. 25 14 (2005) 3701-3711
27. Leppert D., Lindberg R.L., Kappos L., and Leib S.L. Matrix metalloproteinases: multifunctional effectors of inflammation in multiple sclerosis and bacterial meningitis. Brain Res. Brain Res. Rev. 36 2-3 (2001) 249-257
28. Mahajan S.D., Aalinkeel R., Sykes D.E., Reynolds J.L., Bindukumar B., Adal A., Qi M., Toh J., Xu G., Prasad P.N., and Schwartz S.A. Methamphetamine alters blood brain barrier permeability via the modulation of tight junction expression: implication for HIV-1 neuropathogenesis in the context of drug abuse. Brain Res. 1203 (2008) 133-148
29. Mandal M., Mandal A., Das S., Chakraborti T., and Sajal C. Clinical implications of matrix metalloproteinases. Mol. Cell. Biochem. 252 1-2 (2003) 305-329
30. Mun-Bryce S., Lukes A., Wallace J., Lukes-Marx M., and Rosenberg G.A. Stromelysin-1 and gelatinase A are upregulated before TNF-alpha in LPS-stimulated neuroinflammation. Brain Res. 933 1 (2002) 42-49
31. Mun-Bryce S., and Rosenberg G.A. Gelatinase B modulates selective opening of the blood-brain barrier during inflammation. Am. J. Physiol. 274 5 Pt. 2 (1998) R1203-1211
32. Ottino P., Finley J., Rojo E., Ottlecz A., Lambrou G.N., Bazan H.E., and Bazan N.G. Hypoxia activates matrix metalloproteinase expression and the VEGF system in monkey choroid-retinal endothelial cells: involvement of cytosolic phospholipase A2 activity. Mol. Vis. 10 (2004) 341-350
33. Persidsky Y., Ramirez S.H., Haorah J., and Kanmogne G.D. Blood-brain barrier: structural components and function under physiologic and pathologic conditions. J. Neuroimmune. Pharmacol. 1 3 (2006) 223-236
34. Persidsky Y., Stins M., Way D., Witte M.H., Weinand M., Kim K.S., Bock P., Gendelman H.E., and Fiala M. A model for monocyte migration through the blood-brain barrier during HIV-1 encephalitis. J. Immunol. 158 7 (1997) 3499-3510
35. Petty M.A., and Lo E.H. Junctional complexes of the blood-brain barrier: permeability changes in neuroinflammation. Prog. Neurobiol. 68 5 (2002) 311-323
36. Qian L.W., Xie J., Ye F., and Gao S.J. Kaposi's sarcoma-associated herpesvirus infection promotes invasion of primary human umbilical vein endothelial cells by inducing matrix metalloproteinases. J. Virol. 81 13 (2007) 7001-7010
37. Rosenberg G.A. Matrix metalloproteinases in brain injury. J. Neurotrauma. 12 5 (1995) 833-842
38. Rosenberg G.A. Matrix metalloproteinases in neuroinflammation. Glia 39 3 (2002) 279-291
39. Rosenberg G.A., Estrada E.Y., and Mobashery S. Effect of synthetic matrix metalloproteinase inhibitors on lipopolysaccharide-induced blood-brain barrier opening in rodents: differences in response based on strains and solvents. Brain Res. 1133 1 (2007) 186-192
40. Rosenberg G.A., and Yang Y. Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia. Neurosurg. Focus 22 5 (2007) E4
41. Sellner J., Simon F., Meyding-Lamade U., and Leib S.L. Herpes-simplex virus encephalitis is characterized by an early MMP-9 increase and collagen type IV degradation. Brain Res. 1125 1 (2006) 155-162
42. Shigemori Y., Katayama Y., Mori T., Maeda T., and Kawamata T. Matrix metalloproteinase-9 is associated with blood-brain barrier opening and brain edema formation after cortical contusion in rats. Acta Neurochir. Suppl. 96 (2006) 130-133
43. Sporer B., Koedel U., Paul R., Kohleisen B., Erfle V., Fontana A., and Pfister H.W. Human immunodeficiency virus type-1 Nef protein induces blood-brain barrier disruption in the rat: role of matrix metalloproteinase-9. J. Neuroimmunol. 102 2 (2000) 125-130
44. Suzuki Y., Nagai N., Umemura K., Collen D., and Lijnen H.R. Stromelysin-1 (MMP-3) is critical for intracranial bleeding after t-PA treatment of stroke in mice. J. Thromb. Haemost. 5 8 (2007) 1732-1739
45. van Marle G., Antony J., Ostermann H., Dunham C., Hunt T., Halliday W., Maingat F., Urbanowski M.D., Hobman T., Peeling J., and Power C. West Nile virus-induced neuroinflammation: glial infection and capsid protein-mediated neurovirulence. J. Virol. 81 20 (2007) 10933-10949
46. Verma S., Lo Y., Chapagain M., Lum S., Kumar M., Gurjav U., Luo H., Nakatsuka A., and Nerurkar V.R. West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: transmigration across the in vitro blood-brain barrier. Virology 385 (2009) 425-433
47. Verma S., Molina Y., Lo Y.Y., Cropp B., Nakano C., Yanagihara R., and Nerurkar V.R. In vitro effects of selenium deficiency on West Nile virus replication and cytopathogenicity. Virol. J. 5 (2008) 66
48. Verma S., Ziegler K., Ananthula P., Co J.K., Frisque R.J., Yanagihara R., and Nerurkar V.R. JC virus induces altered patterns of cellular gene expression: interferon-inducible genes as major transcriptional targets. Virology 345 2 (2006) 457-467
49. Wang P., Dai J., Bai F., Kong K.F., Wong S.J., Montgomery R.R., Madri J.A., and Fikrig E. Matrix metalloproteinase 9 facilitates West Nile virus entry into the brain. J. Virol. 82 18 (2008) 8978-8985
50. Wang T., Town T., Alexopoulou L., Anderson J.F., Fikrig E., and Flavell R.A. Toll-like receptor 3 mediates West Nile virus entry into the brain causing lethal encephalitis. Nat. Med. 10 12 (2004) 1366-1373
51. Yong V.W., Zabad R.K., Agrawal S., Goncalves Dasilva A., and Metz L.M. Elevation of matrix metalloproteinases (MMPs) in multiple sclerosis and impact of immunomodulators. J. Neurol. Sci. 259 1-2 (2007) 79-84
52. Zozulya A.L., Reinke E., Baiu D.C., Karman J., Sandor M., and Fabry Z. Dendritic cell transmigration through brain microvessel endothelium is regulated by MIP-1alpha chemokine and matrix metalloproteinases. J. Immunol. 178 1 (2007) 520-529